Abstract | OBJECTIVE: METHODS: A retrospective review was performed of patients who underwent retroperitoneal and thoracic/cervical resection of post chemotherapy residual masses between 2002 and 2018. Group 1: "Simultaneous" (Combined Retroperitoneal and Thoracic/Cervical resections on the same date); Group 2: "Sequential" (Retroperitoneal and Thoracic/Cervical resections at separate dates). RESULTS: During the study period, 35 simultaneous and 17 sequential resections were performed. The median age at surgery was 28 years (Range 16-61). The median follow-up from last surgical procedure was 62.7 months (Range 0.4-194). Histology revealed teratoma in 38 (73.1%) patients, necrosis in 8 (15.4%) and viable tumor in 6 (11.5%). Discordant pathology findings between thoracic/cervical and abdominal resections were noted in 16 (30.8%) patients. No differences were observed between the simultaneous vs sequential groups in median operating time (585 minutes vs 545 minutes, P = .64), blood loss (1300 vs 1300 mls, P = .42), or length of stay (9 vs 11 days, P = .14). There was no difference between the 5-year (65.7% vs 68.6%) relapse-free survival between the 2 groups (P = .84) or the 5-year (88.6% vs 100%) overall and disease-specific survival (P = .25). CONCLUSION: Simultaneous resection of retroperitoneal and thoracic/cervical post chemotherapy metastases is a feasible in some patients. It requires multidisciplinary collaboration and a longer primary procedure.
|
Authors | Gregory J Nason, Laura Donahoe, Marc de Perrot, Ishan Aditya, Michael A S Jewett, Philip L Bedard, Aaron R Hansen, Peter Chung, Padraig Warde, Lynn Anson-Cartwright, Joan Sweet, Martin O'Malley, Eshetu G Atenafu, Robert J Hamilton |
Journal | Urology
(Urology)
Vol. 138
Pg. 69-76
(04 2020)
ISSN: 1527-9995 [Electronic] United States |
PMID | 32004556
(Publication Type: Comparative Study, Journal Article)
|
Copyright | Copyright © 2020 Elsevier Inc. All rights reserved. |
Topics |
- Adolescent
- Adult
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Chemotherapy, Adjuvant
- Feasibility Studies
- Humans
- Male
- Middle Aged
- Neck Dissection
(adverse effects, methods, statistics & numerical data)
- Neoadjuvant Therapy
- Neoplasm, Residual
- Neoplasms, Germ Cell and Embryonal
(secondary, therapy)
- Patient Care Team
- Postoperative Complications
(epidemiology, etiology)
- Retroperitoneal Space
(surgery)
- Retrospective Studies
- Testicular Neoplasms
(pathology, secondary, therapy)
- Thoracic Surgical Procedures
(adverse effects, methods, statistics & numerical data)
- Young Adult
|